Explore the words cloud of the SENSITIVE project. It provides you a very rough idea of what is the project "SENSITIVE" about.
The following table provides information about the project.
IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON
|Coordinator Country||Greece [EL]|
|Total cost||2˙965˙326 €|
|EC max contribution||2˙965˙326 € (100%)|
1. H2020-EU.1.2.1. (FET Open)
|Duration (year-month-day)||from 2018-11-01 to 2021-10-31|
Take a look of project's partnership.
|1||IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON||EL (ATHINA)||coordinator||541˙812.00|
|2||HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH||DE (NEUHERBERG)||participant||697˙876.00|
|3||RIVERD INTERNATIONAL BV||NL (ROTTERDAM)||participant||558˙125.00|
|4||ACADEMISCH ZIEKENHUIS GRONINGEN||NL (GRONINGEN)||participant||438˙781.00|
|5||UNIVERSIDAD CARLOS III DE MADRID||ES (GETAFE (MADRID))||participant||362˙187.00|
|6||RAYFOS LTD||UK (BASINGSTOKE)||participant||231˙918.00|
|7||MARIOS LYMARAKIS KAI SIA EE||EL (GERAKAS ATTIKI)||participant||134˙625.00|
Cancer is a major cause of death worldwide. Gastrointestinal (GI) tract tumors are among the most common and deadliest ones. Despite progress in imaging and treatment, the social impact of these diseases is enormous. All parties in the health sector agree that prevention and/or early diagnosis is the most effective means to deal with cancer. Currently, cancer is identified most often when symptomatic or large enough to be visualized in body scans or when histological alterations are already present. What is lacking is an imaging method that could detect tissue changes that facilitate or predict tumor development at an early stage. These alterations, collectively referred to as “field cancerization” is an exciting field of study in cancer biology with profound ramifications in clinical practice. Molecular mechanisms underlying field cancerization are being studied and the advances in molecular biology facilitate these studies. Never in the past however, have these changes been sensed/measured by an imaging modality at the organ level. We thus propose the development of a multimodal microscopy platform that will allow sensing of Raman and scattering properties at the organ level, in order to identify molecular and structural fingerprints of early stage disease in the GI tract. Successful implementation will allow the development of an endoscope especially designed for this purpose that will be used to detect early stage cancer in humans.
|Data Management Plan||Open Research Data Pilot||2020-02-07 15:50:22|
Take a look to the deliverables list in detail: detailed list of SENSITIVE deliverables.
|year||authors and title||journal||last update|
Albert-Smet, Ignacio; Marcos-Vidal, Asier; Vaquero, Juan JosÃ©; Desco, Manuel; MuÃ±oz-Barrutia, Arrate; Ripoll, Jorge
Applications of Light-Sheet Microscopy in Microdevices
published pages: , ISSN: 1662-5129, DOI: 10.3389/fnana.2019.00001
|Frontiers in Neuroanatomy 1||2020-02-05|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SENSITIVE" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "SENSITIVE" are provided by the European Opendata Portal: CORDIS opendata.